Ausgabe 11/2018
Inhalt (14 Artikel)
Evolution of adjuvant treatment in endometrial cancer—no evidence and new questions?
S. Marnitz, C. Köhler, N. Gharbi, S. Kunze, K. Jablonska, J. Herter
A treatment planning study of prone vs. supine positions for locally advanced rectal carcinoma
Sergiu Scobioala, Christopher Kittel, Philipp Niermann, Heidi Wolters, Katharina Helene Susek, Uwe Haverkamp, Hans Theodor Eich
Cost analysis of a wait-and-see strategy after radiochemotherapy in distal rectal cancer
Cihan Gani, Ulrich Grosse, Stephan Clasen, Andreas Kirschniak, Martin Goetz, Claus Rödel, Daniel Zips
The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
Tarkan Jäger, Daniel Neureiter, Mohammad Fallaha, Philipp Schredl, Tobias Kiesslich, Romana Urbas, Eckhard Klieser, Josef Holzinger, Felix Sedlmayer, Klaus Emmanuel, Adam Dinnewitzer
Adenocarcinoma of the oesophagus: neoadjuvant chemoradiation and radical surgery
Stephanie Vitz, Holger Göbel, Bernhard Leibl, Thomas Aigner, Gerhard G. Grabenbauer
Compensatory hypertrophy of the liver after external beam radiotherapy for primary liver cancer
Chai Hong Rim, Sangjoon Park, Joong Yeol Woo, Jinsil Seong
Accuracy assessment of a potential clinical use of navigation-guided intra-operative liver metastasis brachytherapy—a planning study
E. Herrmann, D. Terribilini, P. Manser, M. K. Fix, G. Toporek, D. Candinas, S. Weber, D. M. Aebersold, K. Loessl
Age-corrected hearing loss after chemoradiation in cervical cancer patients
S. Marnitz, L. Schermeyer, S. Dommerich, C. Köhler, H. Olze, V. Budach, P. Martus
Treatment of malnutrition decreases complication rates and shortens the length of hospital stays in a radiation oncology department
Johannes Kufeldt, Marén Viehrig, Daniela Schweikert, Andreas Fritsche, Michael Bamberg, Michael Adolph
Radiation-induced morphea—a rare but severe late effect of adjuvant breast irradiation
Richard Partl, Peter Regitnig, Gerlinde Tauber, Michaela Pötscher, Vesna Bjelic-Radisic, Karin S. Kapp
Aktuelle hormonelle Verhütungsmethoden und das Risiko für Brustkrebs
Georg Sauer
Gibt es einen Zusammenhang zwischen zirkulierenden Tumorzellen und dem Nutzen einer Strahlentherapie bei Brustkrebs im Frühstadium?
Marciana Nona Duma
Nachsorge statt Operation in der Neoadjuvanz beim Ösophaguskarzinom? – Ergebnisse der preSANO-Studie
Philipp Rath, Antje Fahrig